Follow-up of the first patients with a totally subcutaneous ICD in Germany from implantation till battery depletion
Autor: | Florian Reinke, Benjamin Rath, Patrick Leitz, Markus Bettin, Gerrit Frommeyer, Julia Köbe, Christian Ellermann, Lars Eckardt |
---|---|
Rok vydání: | 2018 |
Předmět: |
Adult
Male Battery (electricity) medicine.medical_specialty Time Factors 030204 cardiovascular system & hematology Ventricular tachycardia Sudden cardiac death 03 medical and health sciences 0302 clinical medicine Primary prevention Internal medicine medicine Humans In patient Prospective Studies Registries 030212 general & internal medicine Prospective cohort study business.industry General Medicine medicine.disease Defibrillators Implantable Surgery Primary Prevention Death Sudden Cardiac Treatment Outcome Baseline characteristics Tachycardia Ventricular Cardiology Female Cardiology and Cardiovascular Medicine business Complication Follow-Up Studies |
Zdroj: | Clinical Research in Cardiology. 108:16-21 |
ISSN: | 1861-0692 1861-0684 |
DOI: | 10.1007/s00392-018-1296-1 |
Popis: | The subcutaneous ICD is a promising treatment option in patients at risk for sudden cardiac death. Approved in 2009, the first S-ICD® in Germany was implanted in June 2010. Although large prospective registry studies have shown safety and efficacy of the system, there is a lack of long-term data with regard to battery longevity of the S-ICD®. Therefore, we report follow-up of our first initial S-ICD® cases from implantation till battery depletion. All S-ICD® patients with device replacement for battery depletion in our large single-center S-ICD® registry were included in this study. Baseline characteristics, appropriate and inappropriate shocks, and complications were documented in a median follow-up of 75.9 ± 6.8 months. Twenty-eight patients with S-ICD® systems were included in this study. Of these patients, 21 were male and 7 were female, with an overall mean age of 41.9 ± 12.6 years. Primary prevention of sudden cardiac death was the indication in 19 patients (67.9%). Ventricular tachycardia was adequately terminated in two patients (7.1%). In 7 patients, non-sustained ventricular arrhythmias were not treated. A total of three inappropriate shocks occurred in three patients (10.7%). Mean time from implantation till battery depletion was 65.8 ± 8.1 months. Only one patient presented premature elective replacement criteria because of rapid battery depletion. No lead-related complication occurred during follow-up and no complications were seen regarding device replacement. In one patient (3.6%), the system was explanted without replacement due to patient’s preference. The estimated battery longevity of S-ICD® of about 5 years was reached in all but one patient. Compared to larger S-ICD® registry studies, frequency of inappropriate shocks was relatively high in the initial S-ICD® cases. Both technological improvement as well as programming and operators’ experience have led to a reduction of complications. Replacement of the S-ICD® seems to be a safe and effective procedure. |
Databáze: | OpenAIRE |
Externí odkaz: |